This Solicitation opportunity from Government of Canada was posted on March 10, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

FABRICATION DE CAPSULES POUR DES TENEURS COMMERCIALEMENT NON DISPONIBLES

Closed

20127852Canada

Submission Closed04/02/2026, 01:30:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

ANALGESIC GEL, TOPICThe contract involves the procurement of topical analgesic gel identified by NSN 6505-01-658-7643, with a quantity of one unit requested under purchase request number 7017120837. This solicitation, numbered SPE2DP-26-T-3782, was posted on June 11, 2026, with a response deadline set for June 17, 2026. The solicitation is issued by the Defense Logistics Agency, which operates under the Department of Defense. The contract is a federal solicitation with no specified set-aside type or NAICS code provided. The place of performance and office address details are not explicitly stated, and no specific point of contact information is included in the contract data. The procurement is expected to support federal needs, particularly those managed by defense logistics, emphasizing timely response and adherence to the solicitation timeline.

Defense Logistics Agency

POSTED

DEADLINE

6505--762-26-3-040-2307 -Tucson CMOP PROPRANOLOL -(VA-26-00068676)The Department of Veterans Affairs, through its Network Contracting Office 15 and CMOP Division, plans to solicit quotes for the procurement of three pharmaceuticals to be delivered to the Ladson (Charleston) CMOP and Tucson CMOP locations. This solicitation, identified as RFQ 36C77026Q0147, is designated as a total small business set-aside under NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. The estimated issue date for the solicitation is June 11, 2026, with responses due by June 18, 2026. All qualified small business vendors are encouraged to submit concise quotations in response to this requirement. Vendors must provide a valid and unexpired state wholesale distributor license demonstrating compliance with the Drug Supply Chain Security Act along with their submission, or they will be deemed non-compliant. Responses must include a signed SF1449 solicitation cover page, a price schedule in Excel format specifying the place of manufacture, the state wholesale distributor license, and a completed Buy American Act certificate. All submissions are to be sent via email to the designated contracting specialists, with contact information provided for questions. Offerors are responsible for monitoring any amendments posted on SAM.gov regarding this solicitation. The effort supports the Department of Veterans Affairs’ commitment to sourcing pharmaceuticals through small businesses while ensuring regulatory compliance and timely delivery.

National Cmop Office (36C770)

POSTED

DEADLINE

LORATADINE TABLETSThe contract pertains to the procurement of Loratadine tablets, identified under the National Stock Number 6505-01-524-9179, with a requested quantity of four units. It is issued by the Defense Logistics Agency within the Department of Defense as a federal solicitation with the reference number SPE2DP-26-T-3776. The solicitation was posted on June 10, 2026, and the deadline for responses is June 16, 2026. The solicitation does not specify any type of set aside or NAICS code, and details regarding the place of performance or specific office addresses are not provided. This contract opportunity is open to federal organizations, and interested parties can access further information through the official procurement website linked with the Defense Logistics Agency.

Defense Logistics Agency

POSTED

DEADLINE

INHALER, SPACING DEVThe contract pertains to the procurement of inhaler spacing devices, identified by the National Stock Number 6515-01-538-2141, with a quantity of five units requested. The solicitation, numbered SPE2DS-26-T-146M, was issued by the Defense Logistics Agency under the Department of Defense. The solicitation was posted on June 10, 2026, and responses were due by June 16, 2026. This is a federal procurement effort, although there is no specified type of set-aside or detailed NAICS code provided. The place of performance and detailed office address are not disclosed in the contract data, and no specific point of contact information is listed. The procurement is managed through the DLA’s bidding platform.

Defense Logistics Agency

POSTED

DEADLINE

Radioactive Isotope Preparation and EncapsulationThe contract involves the preparation and encapsulation of radioactive calibration standards utilizing isotopes such as Cd-109, Cs-137, and Co-60. These isotopes are to be incorporated into various matrices and container types while ensuring uniform distribution and proper sealing to meet regulatory and safety requirements. The work is associated with the Environmental Protection Agency and is designated as a subcontract under the NAICS code 325412. The solicitation was posted on June 10, 2026, with a response deadline of June 16, 2026. The contract focuses on precise and compliant handling of radioactive materials to produce reliable calibration standards necessary for environmental and safety monitoring purposes. Specific location details and contact information are not provided, and interested parties are directed to the official FedConnect link for further information.

Lead

POSTED

1 day ago

DEADLINE

in 5 days

AI Contract Overview

The Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec (CIUSSS MCQ) is seeking the fabrication of capsules with dosages that are not commercially available. The estimated annual quantity required is approximately 642,000 doses. This solicitation, identified by the number 20127852, was posted on March 10, 2026, with a submission deadline set for April 2, 2026, at 1:30 PM. The contract is issued under the federal government and pertains to specialized pharmaceutical manufacturing to fulfill specific dosage needs. The place of performance for the contract is located in the Centre-du-Québec and Mauricie regions. The contracting authority overseeing this solicitation is Marie-Claude Giguère, who can be contacted via email or phone for further information. This initiative addresses a critical healthcare supply need, ensuring that the CIUSSS MCQ can provide appropriate medications to its patients by obtaining custom-manufactured capsules that meet precise dosing requirements unavailable through standard commercial channels.

General Info

CIUSSS MCQ seeks custom capsules, 642,000 doses annually, deadline April 2, 2026, Québec regions.

Agency

Government of Canada → Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec (CIUSSS MCQ)

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

Centre-du-Québec, Mauricie, CAN

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed

PostedMar 10

Solicitation

Response DeadlineApr 2

Deadline has passed

Submission Closed

04/02/2026, 01:30:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyGovernment of Canada → Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec (CIUSSS MCQ)

Contacts1 person available

OfficeN/A

Organization / Agency

Government of Canada → Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec (CIUSSS MCQ)

Office AddressN/A

Contacts

Giguère Marie-ClaudeContracting Authority

contact@example.gov

+1 (555) 000-0000

Full Description

Le CIUSSS de la Mauricie-et-du-Centre-du-Québec désire obtenir des capsules pour des teneurs commercialement non disponibles. La quantité annuelle estimée est d'environ 642 000 doses.